Systemic Juvenile Idiopathic Arthritis
Musculoskeletal
Systemic Juvenile Idiopathic Arthritis is treated with 1 medication in our database, including AVTOZMA. 1 of these has manufacturer assistance programs available to help reduce out-of-pocket costs. Medications are manufactured by Celltrion. Patients and caregivers can find copay cards, patient assistance programs, and travel grants for Systemic Juvenile Idiopathic Arthritis treatment below.
What help exists for Systemic Juvenile Idiopathic Arthritis
5
drugs indexed
5
with copay cards
5
with patient assistance
0
open travel grants
Every item below links to the manufacturer's or charity's own portal. RxCopays does not take referral fees.
Drugs used to treat Systemic Juvenile Idiopathic Arthritis
5 totalAVTOZMA
tocilizumab · Celltrion
🎟💙Tocilizumab-anoh
tocilizumab · Sandoz
🎟💙TOFIDENCE
Tocilizumab · Biogen
🎟💙Ilaris
canakinumab
🎟💙GAMIFANT
emapalumab-lzsg · Sobi
🎟💙
🎟 = copay card · 💙 = patient assistance program
Prior authorization patterns for Systemic Juvenile Idiopathic Arthritis drugs
Aggregated from CMS SPUF + commercial PBM formularies. Specific rules vary by plan; confirm with your insurer.
| Payer | PA | Step therapy | Copay tier |
|---|---|---|---|
— Medicare Part D | — | — | — |
— Medicare Part D | Yes | — | — |
— Medicare Part D | — | — | — |
— Medicare Part D | — | — | — |
— Medicare Part D | — | — | — |
— Medicare Part D | — | — | — |